UPDATE: BofA/Merrill Lynch Downgrades ViroPharma (VPHM) to Underperform
Tweet Send to a Friend
(Updated - September 18, 2013 10:28 AM EDT)
BofA/Merrill Lynch downgraded ViroPharma (NASDAQ: VPHM) from Neutral to Underperform with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA/Merrill Lynch downgraded ViroPharma (NASDAQ: VPHM) from Neutral to Underperform with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
